Coignard, J.,
Lush, M.,
Beesley, J.,
O’Mara, T.A.,
Dennis, J,
Tyrer, J.P.,
Barnes, D.R.,
McGuffog, L.,
Leslie, G.,
Bolla, M.K.,
Adank, M.A.,
Kiiski, J.I.,
Nevanlinna, H.,
team of authors (2021) Breast cancer (BC) risk for BRCA1 and BRCA
2 mutation carriers varies by genetic and familial
a combination of prototype M1 and M
2 genes. Our review focuses on novel mechanisms involved
Mingyu, He,
Gege, Yan,
Yang, Wang,
Gong, Rui,
Lei, Hong,
Yu, Shuting,
He, Xiaoqi,
Li, Guanghui,
Du, Weijie,
Ma, Tianshuai,
Gao, Manqi,
Yu, Meixi,
Liu, Shenzhen,
Xu, Zihang,
Idiiatullina, Elina,
Zagidullin, Naufal,
Pavlov, Valentin,
Cai, Benzhi,
Yuan, Ye,
Yang, Lei (2021) production through increased NADPH oxidase enzymes NOX
2 and NOX4, as well as decreased Catalase (CAT
by the modifications of cell cycle-related genes or regulation of
growth-related signals. Additionally, non
Parfenova, Lyudmila V.,
Galimshina, Zulfiya R.,
Gil’fanova, Guzel U.,
Alibaeva, Eliza I.,
Danilko, Ksenia V.,
Aubakirova, Veta R.,
Farrakhov, Ruzil G.,
Parfenov, Evgeny V.,
Valiev, Ruslan Z. (2022) factors determining metal biocompatibility, among others, include the morphology and chemical composition